KSS
51
2
AVGO
76
10
SLG
75
2
C
55
-3
AA
51
7
INTC
62
4
UNP
55
2
EXPD
53
3
AFL
53
-2
MAC
64
4
NAVI
52
2
STZ
60
-4
ZBH
54
3
RIG
43
2
INTU
74
2
HPE
72
-6
WAT
41
3
CCI
36
3
PSA
43
2
AMZN
60
-3
KSS
51
2
AVGO
76
10
SLG
75
2
C
55
-3
AA
51
7
INTC
62
4
UNP
55
2
EXPD
53
3
AFL
53
-2
MAC
64
4
NAVI
52
2
STZ
60
-4
ZBH
54
3
RIG
43
2
INTU
74
2
HPE
72
-6
WAT
41
3
CCI
36
3
PSA
43
2
AMZN
60
-3
Financhill
Back

BridgeBio Pharma 10K Form

Sell
35

BBIO
BridgeBio Pharma

Last Price:
24.98
Seasonality Move:
12.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BBIO News And Ratings

See the #1 stock for the next 7 days that we like better than BBIO

BBIO Financial Statistics

Sales & Book Value

Annual Sales: $9.3M
Cash Flow: $-221.03M
Price / Cash Flow: 0
Annual Sales: $-5.61
Price / Book: 0

Profitability

EPS (TTM): -3.22000
Net Income (TTM): $-538.26M
Gross Margin: $6.86M
Return on Equity: 0%
Return on Assets: -84.63%

BridgeBio Pharma Earnings Forecast

Key BridgeBio Pharma Financial Ratios

  • The Gross Profit Margin over the past 7 years for BBIO is 73.71%.
  • The Selling, General & Administrative Expenses for BBIO have been equal to 1,618.73% of Gross Profit Margin.
  • The Research & Development expenses have been 4,898.54% of Revenue.
  • The Interest Expense is -12.64% of Operating Income.
  • The Net Earning history of BBIO is -6,913.92% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

BridgeBio Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BBIO
CUSIP: 10806X
Website: bridgebio.com

Debt

Debt-to-Equity Ratio: -1.64
Current Ratio: 5.54
Quick Ratio: 5.34

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BBIO Technical Analysis vs Fundamental Analysis

Sell
35
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma a Buy or a Sell?

  • BridgeBio Pharma stock is rated a Sell
    The current BridgeBio Pharma [BBIO] share price is $25.00. The Score for BBIO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.